PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health
February 05, 2009
PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health
It was not immediately clear whether PerkinElmer would divest all of its proteomics assets or retain a portion of them, though it described them as “discontinued operations” during its fourth-quarter earnings statement.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BioArray Briefs
February 3, 2009 / BioArray News - People in the News
May 1, 2009 / GenomeWeb Daily News - With Reproducibility Proven, New Study May Engender 2D Gel Standards, Protocols, References
March 26, 2009 / ProteoMonitor - People in the News
February 20, 2009 / GenomeWeb Daily News - NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent
February 5, 2009 / ProteoMonitor